Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs iShares Semiconductor ETF (SOXX) Price & Performance

Iovance Biotherapeutics Inc. Common StockTrade
iShares Semiconductor ETFTrade

Price performance (Past 24H)

Key statistics

Iovance Biotherapeutics Inc. Common Stock vs iShares Semiconductor ETF — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.69 (market cap $6.04B), while iShares Semiconductor ETF trades at $560.4 (market cap $48.19B). The key difference: iShares Semiconductor ETF is far larger — about 8× Iovance Biotherapeutics Inc. Common Stock's market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, iShares Semiconductor ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and iShares Semiconductor ETF for 46 Days on average.

IOVASOXX
Market Cap
$6.04B$48.19B
Volume
14,805,99310,257,578
Sector
HealthSector/Thematic
52-Week High
$14.82$655.01
52-Week Low
$1.81$268.10
Typical Hold Time
0 Days46 Days
Enterprise Value
$5.97B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Iovance Biotherapeutics Inc. Common Stock

No Aura AI signal available yet.

iShares Semiconductor ETF

SOXX trades at $559.67, down 3.99% on the day but maintains a bullish technical outlook with strong moving average signals. The semiconductor ETF benefits from AI-driven demand, with Bank of America projecting the global chip market could nearly double by 2030. Recent news highlights strong September performance and ongoing institutional interest, though Michael Burry's expanded short position signals some bearish sentiment.

The outlook remains positive given structural AI growth catalysts, but investors face valuation concerns with SOXX trading at a P/E premium versus broader markets. Key risks include concentration in top holdings and potential AI development slowdowns. Wall Street maintains generally bullish ratings based on earnings growth potential.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IOVA
51% Buy49% Sell
Avg holding period · 0 Days
SOXX
40% Buy60% Sell
Avg holding period · 46 Days

Top news

Latest headlines on both assets

About Iovance Biotherapeutics Inc. Common Stock

Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.

Read more on IOVA →

About iShares Semiconductor ETF

SOXX provides investors with exposure to U.S. companies that design, manufacture, and distribute semiconductors. It tracks the ICE Semiconductor Index, offering a targeted investment in the technology sector's foundational components, including firms that produce chips, related equipment, and services. SOXX is a key vehicle for investors seeking to capitalize on trends in artificial intelligence, 5G, and other technologies that rely heavily on advanced semiconductor technology.

Read more on SOXX →